Black Swift Group’s Amgen AMGN Stock Holding History

Black Swift Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-21	Closed	-$4K	–	77
2018 Q4	$4K	Hold	21	–	–	0.01%	43
2018 Q3	$4K	Buy	+21	New	+$4.14K	﹤0.01%	68

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Black Swift Group's AMGN Position: Q1 2019 in Review

Black Swift Group sold out of Amgen (AMGN) in Q1 2019, closing a stake of 21 shares — an estimated $4K sold.

Black Swift Group first reported a position in AMGN in Q3 2018 and held it in 2 quarters. The position peaked at $4K in Q4 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Black Swift Group reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
Black Swift Group sold 21 Amgen shares in Q1 2019, an estimated $4K.
Black Swift Group first reported a position in Amgen in Q3 2018 and held it in 2 quarters.
Black Swift Group's Amgen position peaked at $4K in Q4 2018.
1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Black Swift Group's 13F filing for Q1 2019, filed 10 Feb 2021.